
March 9 (Reuters) - Dianthus Therapeutics Inc DNTH.O:
DIANTHUS THERAPEUTICS, INC. ANNOUNCES PROPOSED $400 MILLION UNDERWRITTEN PUBLIC OFFERING
DIANTHUS THERAPEUTICS INC - TO USE NET PROCEEDS FOR CLINICAL, COMMERCIAL, WORKING CAPITAL, AND CORPORATE PURPOSES